Barrett's esophagus secondary prevention: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Barrett's esophagus}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{...") |
Pal Manickam (talk | contribs) |
||
| Line 3: | Line 3: | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
==Secondary prevention== | |||
Recommendations: | |||
* Therapy with medicationeffective to treat GERD symptoms and to heal reflux esophagitis is strongly recommended. | |||
* Do not attempt to eliminate acid exposure of the esophagus | |||
# Use proton pump inhibitors in doses greater than once daily. There is no evidence that higher doses produce a risk reduction in cancer. | |||
# Titrate proton pump inhibitors dose by esophageal pH monitoring. | |||
# Antireflux surgery. This is not more effective than medical therpay. | |||
Risks and benefits of long-term PPI therapy should be discussed with the patients. | |||
* Do not use aspirin to prevent esophageal adenocarcinoma in the absence of other indications (e.g. cardiovascular risk factors). Although evidence suggests NSAIDs may decrease the incidence of esophageal cancer, it is not clear if benefits outweight the risks of using this medications.<ref name="pmid21376940">{{cite journal |author=Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ |title=American Gastroenterological Association medical position statement on the management of Barrett's esophagus |journal=Gastroenterology |volume=140 |issue=3 |pages=1084–91 |year=2011 |month=March |pmid=21376940 |doi=10.1053/j.gastro.2011.01.030 |url=}}</ref> | |||
==References== | ==References== | ||
Revision as of 01:34, 24 December 2012
|
Barrett's Esophagus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Barrett's esophagus secondary prevention On the Web |
|
American Roentgen Ray Society Images of Barrett's esophagus secondary prevention |
|
Risk calculators and risk factors for Barrett's esophagus secondary prevention |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Secondary prevention
Recommendations:
- Therapy with medicationeffective to treat GERD symptoms and to heal reflux esophagitis is strongly recommended.
- Do not attempt to eliminate acid exposure of the esophagus
- Use proton pump inhibitors in doses greater than once daily. There is no evidence that higher doses produce a risk reduction in cancer.
- Titrate proton pump inhibitors dose by esophageal pH monitoring.
- Antireflux surgery. This is not more effective than medical therpay.
Risks and benefits of long-term PPI therapy should be discussed with the patients.
- Do not use aspirin to prevent esophageal adenocarcinoma in the absence of other indications (e.g. cardiovascular risk factors). Although evidence suggests NSAIDs may decrease the incidence of esophageal cancer, it is not clear if benefits outweight the risks of using this medications.[1]
References
- ↑ Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ (2011). "American Gastroenterological Association medical position statement on the management of Barrett's esophagus". Gastroenterology. 140 (3): 1084–91. doi:10.1053/j.gastro.2011.01.030. PMID 21376940. Unknown parameter
|month=ignored (help)